Energetic returns | Recovery play
News covered in our update here includes an introduction to a small company that has secured a huge contract in a very big market. Elsewhere, there were excellent results from a medical device company but results from one large AIM company didn’t offer much of a guide to its future potential. A renewable energy company has also been transformed following a series of acquisitions. Read on here for our usual forthright observations. (Premium)
NIOX: great results and plenty of delightful cash
NIOX Group (AIM: NIOX), amedical device company focused on point of care asthma diagnosis and management, announced impressive results for the year ended 31 December 2023.
NIOX’s stated mission is to improve asthma diagnosis and management by greater patient access to FeNO testing. Asthma is one of the biggest healthcare issues globally with 340 million sufferers, many of whom are undiagnosed or are misdiagnosed. NIOX…
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
